Triomics Analysis: $15M Raised
What is Triomics?
Triomics builds AI products for oncology teams that turn unstructured cancer records into cited, structured outputs. The company’s platform supports trial matching, visit preparation, pre-charting, and cancer registry curation across cancer centers and life sciences workflows. Its site reports 120,000 plus charts read monthly, 65,000 plus patients screened for trials monthly, and trust from 4 of the top 10 U.S. cancer centers.
Location
285 Fulton St, New York, NY 10007, US
Employees
51-200
Founded
2021
Revenue
$9.3-10.5M
Product Features & Capabilities
- Trial Enrollment, Patient-to-Trial Matching, Clinical Navigators, Quality Improvement, Care Operations, Triaging, Scheduling and Pre-Charting
Pricing
- Pricing is based on a subscription model.
- Detailed pricing plans are not publicly available.
- Custom solutions are offered, with pricing varying based on scale and customization.
- Interested parties should contact Triomics directly for specific pricing information.
How much Triomics raised
Series A - $15 million
May 9, 2024Lead Investor: Lightspeed Venture Partners, Nexus Venture Partners, and others.
Who are the founders of Triomics
Market Focus
Triomics primarily focuses on the healthcare industry, specifically in oncology research and care operations, utilizing generative AI to enhance trial enrollment and streamline healthcare processes.
Investors
- Lightspeed Venture Partners
- General Catalyst
- Nexus Venture Partners
- Y Combinator
Competitors Overview
Triomics operates in the oncology research and healthcare technology market, focusing on enhancing trial enrollment and streamlining operations through generative AI. Its main competitors include:
- Vim: Known for its configurable text editing capabilities, Vim enhances patient acquisition and retention through modern features.
- NexHealth: This platform focuses on patient management, offering tools that improve patient engagement and streamline healthcare operations.
- Redox: Specializes in data integration and standardization, crucial for healthcare providers to maintain seamless operations across different systems.
- Definitive Healthcare: Provides comprehensive data on healthcare providers, which can be beneficial for research and operational insights.
- Iguana: Offers a platform for building and troubleshooting healthcare interfaces, facilitating better integration of healthcare data.
Additionally, larger competitors include:
- Medidata: Offers AI-based clinical trial management software and has significant funding, making it a strong player in the market.
- Verily: Provides a comprehensive AI-based suite for health management, with substantial financial backing.
- TriNetX: Focuses on clinical trial management software and has raised considerable funds, positioning it as a notable competitor.
Triomics is ranked 19th among 267 active competitors, indicating a competitive landscape where larger players have significant market presence and funding advantages.
Business Model
Partners with healthcare providers, leveraging AI for workflow optimization and revenue sharing.
See something that needs updating? Suggest edits to this profile.